Significance of thymidine kinase activity in renal cell carcinoma

被引:11
|
作者
Mizutani, Y [1 ]
Wada, H
Yoshida, O
Fukushima, M
Nakao, M
Miki, T
机构
[1] Kyoto Prefectural Univ Med, Dept Urol, Kyoto, Japan
[2] Kyoto Univ, Fac Med, Grad Sch Med, Dept Urol, Kyoto, Japan
[3] Kyoto Univ, Fac Med, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan
来源
JOURNAL OF UROLOGY | 2003年 / 169卷 / 02期
关键词
kidney; carcinoma; renal cell; thymidine kinase; fluorouracil; thymidylate synthase;
D O I
10.1016/S0022-5347(05)63997-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Thymidine kinase (TK) has a key role in the complementary or alternative salvage pathway of pyrimidine synthesis. Little is known about the significance of TK activity in renal cell carcinoma. We examined the activity of TK in 66 renal cell carcinomas and investigated the association of the level of TK activity with the stage and grade of renal cell carcinoma. Materials and Methods: TK activity in nonfixed, fresh frozen renal cell carcinoma and normal kidney was determined by the DEAE cellulose disc method. Results: The activity of TK was approximately 4-fold higher in normal kidney compared with renal cell carcinoma. The higher the stage and grade of renal cell carcinoma, the higher the TK activity. TK activity correlated positively with the activity of thymidine syntliase, which is a key enzyme for pyrimidine synthesis in the de novo pathway. TK activity in renal cell carcinoma cells was inversely related to their sensitivity to 5-fluorouracil. Conclusions: To our knowledge this report represents the first study to demonstrate that the level of TK activity correlates with the stage and grade of renal cell carcinoma, and higher TK activity in renal cell carcinoma predicts lower sensitivity to 5-fluorouracil. These results suggest that high TK activity may be associated with the malignant potential of renal cell carcinoma and TK may be a molecular therapeutic target for this disease. In addition, the combination of TK and thymidylate synthase inhibitors may be beneficial for renal cell carcinoma.
引用
收藏
页码:706 / 709
页数:4
相关论文
共 50 条
  • [21] The assay and clinical significance of serum thymidine kinase 1 in patients with colorectal carcinoma
    Y. Zhang
    J. Wang
    J. Xie
    D. Yang
    G. Han
    Y. Zhang
    Q. Fu
    European Surgery, 2015, 47 : 248 - 253
  • [22] Enhanced orotate phosphoribosyltransferase activity in renal cell carcinoma and its prognostic significance
    Mizutani, Y.
    Toiyama, D.
    Shiraishi, T.
    Nakamura, T.
    Mikami, K.
    Takaha, N.
    Okihara, K.
    Ukimura, O.
    Kawauchi, A.
    Miki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Thymidine phosphorylase levels as a prognostic factor in renal cell carcinoma
    Wada, S
    Yoshimura, R
    Naganuma, T
    Yoshida, N
    Narita, K
    Ikemoto, S
    BJU INTERNATIONAL, 2003, 91 (01) : 105 - 108
  • [24] THYMIDINE KINASE-ACTIVITY ON SYNCHRONOUS CELL-CULTURES
    SIEGERS, MP
    SCHINDLE.R
    MAURER, U
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 102 (25) : 894 - &
  • [25] The clinical significance of lymphangiogenesis in renal cell carcinoma
    Debinski, Pawel
    Dembowski, Janusz
    Kowal, Pawel
    Szydelko, Tomasz
    Kolodziej, Anna
    Malkiewicz, Bartosz
    Tupikowski, Krzysztof
    Zdrojowy, Romuald
    MEDICAL SCIENCE MONITOR, 2013, 19 : 606 - 611
  • [26] Functional significance of erythropoietin in renal cell carcinoma
    Morais, Christudas
    Johnson, David W.
    Vesey, David A.
    Gobe, Glenda C.
    BMC CANCER, 2013, 13
  • [27] Prognostic significance of thrombocytosis in renal cell carcinoma
    Bensalah, K
    Tostain, J
    Vincendeau, S
    Manunta, A
    Rioux-Leclercq, N
    Lobel, B
    Guillè, F
    Patard, JJ
    JOURNAL OF UROLOGY, 2004, 171 (04): : 200 - 200
  • [28] Heterogeneity in renal cell carcinoma, prognostic significance
    Ljungberg, B
    Mehle, C
    Roos, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 462 - 462
  • [29] Functional significance of erythropoietin in renal cell carcinoma
    Christudas Morais
    David W Johnson
    David A Vesey
    Glenda C Gobe
    BMC Cancer, 13
  • [30] Protein kinase inhibitors in renal cell carcinoma
    Daste, Amaury
    Grellety, Thomas
    Gross-Goupil, Marine
    Ravaud, Alain
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (03) : 337 - 351